Series A - āshibio

Series A - āshibio

Investment Firm

Overview

āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.

Announced Date

Jun 20, 2024

Closed on Date

Jun 20, 2024

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

MPM Capital

MPM Capital

MPM Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

3

Investor Name
Participant InvestorYK Bioventures
Participant InvestorMirae Asset Venture Investment
Participant InvestorMPM Capital

Round Details and Background

āshibio raised $40000000 on 2024-06-20 in Series A

āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 20, 2024
Series A - āshibio
4-40.0M

Recent Activity

There is no recent news or activity for this profile.